Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 99

1.

Triplet state homoaromaticity: concept, computational validation and experimental relevance.

Jorner K, Jahn BO, Bultinck P, Ottosson H.

Chem Sci. 2018 Feb 19;9(12):3165-3176. doi: 10.1039/c7sc05009g. eCollection 2018 Mar 28.

2.

Micropatterning as a tool to identify regulatory triggers and kinetics of actin-mediated endothelial mechanosensing.

Gegenfurtner FA, Jahn B, Wagner H, Ziegenhain C, Enard W, Geistlinger L, Rädler JO, Vollmar AM, Zahler S.

J Cell Sci. 2018 May 29;131(10). pii: jcs212886. doi: 10.1242/jcs.212886.

PMID:
29724912
3.

Similar but Not the Same: First Kinetic and Structural Analyses of a Methanol Dehydrogenase Containing a Europium Ion in the Active Site.

Jahn B, Pol A, Lumpe H, Barends TRM, Dietl A, Hogendoorn C, Op den Camp HJM, Daumann LJ.

Chembiochem. 2018 Mar 11. doi: 10.1002/cbic.201800130. [Epub ahead of print]

4.

Embodied Cognition and the Direct Induction of Affect as a Compliment to Cognitive Behavioural Therapy.

Pietrzak T, Lohr C, Jahn B, Hauke G.

Behav Sci (Basel). 2018 Feb 26;8(3). pii: E29. doi: 10.3390/bs8030029.

5.

Development of a novel prognostic score for breast cancer patients using mRNA expression of CHAC1.

Jahn B, Arvandi M, Rochau U, Fiegl H, Goebel G, Marth C, Siebert U.

J Comp Eff Res. 2017 Oct;6(7):563-574. doi: 10.2217/cer-2017-0015. Epub 2017 Sep 19.

PMID:
29091014
6.

Personalized treatment of women with early breast cancer: a risk-group specific cost-effectiveness analysis of adjuvant chemotherapy accounting for companion prognostic tests OncotypeDX and Adjuvant!Online.

Jahn B, Rochau U, Kurzthaler C, Hubalek M, Miksad R, Sroczynski G, Paulden M, Bundo M, Stenehjem D, Brixner D, Krahn M, Siebert U.

BMC Cancer. 2017 Oct 16;17(1):685. doi: 10.1186/s12885-017-3603-z.

7.

The Long-Term Effectiveness and Cost Effectiveness of Organized versus Opportunistic Screening for Breast Cancer in Austria.

Schiller-Fruehwirth I, Jahn B, Einzinger P, Zauner G, Urach C, Siebert U.

Value Health. 2017 Sep;20(8):1048-1057. doi: 10.1016/j.jval.2017.04.009. Epub 2017 May 16.

8.

Active Surveillance Versus Watchful Waiting for Localized Prostate Cancer: A Model to Inform Decisions.

Loeb S, Zhou Q, Siebert U, Rochau U, Jahn B, Mühlberger N, Carter HB, Lepor H, Braithwaite RS.

Eur Urol. 2017 Dec;72(6):899-907. doi: 10.1016/j.eururo.2017.07.018. Epub 2017 Aug 23.

PMID:
28844371
9.

Cost-Effectiveness Models in Breast Cancer Screening in the General Population: A Systematic Review.

Schiller-Frühwirth IC, Jahn B, Arvandi M, Siebert U.

Appl Health Econ Health Policy. 2017 Jun;15(3):333-351. doi: 10.1007/s40258-017-0312-3. Review.

PMID:
28185134
10.

Metal-free photochemical silylations and transfer hydrogenations of benzenoid hydrocarbons and graphene.

Papadakis R, Li H, Bergman J, Lundstedt A, Jorner K, Ayub R, Haldar S, Jahn BO, Denisova A, Zietz B, Lindh R, Sanyal B, Grennberg H, Leifer K, Ottosson H.

Nat Commun. 2016 Oct 6;7:12962. doi: 10.1038/ncomms12962.

11.

Integrated MRSA-Management (IMM) with prolonged decolonization treatment after hospital discharge is effective: a single centre, non-randomised open-label trial.

Jahn B, Wassenaar TM, Stroh A.

Antimicrob Resist Infect Control. 2016 Jun 14;5:25. doi: 10.1186/s13756-016-0124-5. eCollection 2016.

12.

Cost effectiveness of personalized treatment in women with early breast cancer: the application of OncotypeDX and Adjuvant! Online to guide adjuvant chemotherapy in Austria.

Jahn B, Rochau U, Kurzthaler C, Hubalek M, Miksad R, Sroczynski G, Paulden M, Kluibenschädl M, Krahn M, Siebert U.

Springerplus. 2015 Dec 1;4:752. doi: 10.1186/s40064-015-1440-6. eCollection 2015.

13.

Systematic overview of cost-effectiveness thresholds in ten countries across four continents.

Schwarzer R, Rochau U, Saverno K, Jahn B, Bornschein B, Muehlberger N, Flatscher-Thoeni M, Schnell-Inderst P, Sroczynski G, Lackner M, Schall I, Hebborn A, Pugner K, Fehervary A, Brixner D, Siebert U.

J Comp Eff Res. 2015 Sep;4(5):485-504. doi: 10.2217/cer.15.38.

PMID:
26490020
14.

Lessons Learned from a Cross-Model Validation between a Discrete Event Simulation Model and a Cohort State-Transition Model for Personalized Breast Cancer Treatment.

Jahn B, Rochau U, Kurzthaler C, Paulden M, Kluibenschädl M, Arvandi M, Kühne F, Goehler A, Krahn MD, Siebert U.

Med Decis Making. 2016 Apr;36(3):375-90. doi: 10.1177/0272989X15604158. Epub 2015 Oct 16.

PMID:
26476865
15.

Oncotyrol--Center for Personalized Cancer Medicine: Methods and Applications of Health Technology Assessment and Outcomes Research.

Siebert U, Jahn B, Rochau U, Schnell-Inderst P, Kisser A, Hunger T, Sroczynski G, Mühlberger N, Willenbacher W, Schnaiter S, Endel G, Huber L, Gastl G; Oncotyrol HTA & Outcomes Research Working Group.

Z Evid Fortbild Qual Gesundhwes. 2015;109(4-5):330-40. doi: 10.1016/j.zefq.2015.06.012. Epub 2015 Jul 28.

PMID:
26354133
16.

The 6,6-dicyanopentafulvene core: a template for the design of electron-acceptor compounds.

Finke AD, Jahn BO, Saithalavi A, Dahlstrand C, Nauroozi D, Haberland S, Gisselbrecht JP, Boudon C, Mijangos E, Schweizer WB, Ott S, Ottosson H, Diederich F.

Chemistry. 2015 May 26;21(22):8168-76. doi: 10.1002/chem.201500379. Epub 2015 Apr 27.

PMID:
25917111
17.

Decision-analytic modeling studies: An overview for clinicians using multiple myeloma as an example.

Rochau U, Jahn B, Qerimi V, Burger EA, Kurzthaler C, Kluibenschaedl M, Willenbacher E, Gastl G, Willenbacher W, Siebert U.

Crit Rev Oncol Hematol. 2015 May;94(2):164-78. doi: 10.1016/j.critrevonc.2014.12.017. Epub 2014 Dec 31. Review.

PMID:
25620327
18.

Use of DALYs in economic analyses on interventions for infectious diseases: a systematic review.

Oostvogels AJ, De Wit GA, Jahn B, Cassini A, Colzani E, De Waure C, Kretzschmar ME, Siebert U, Mühlberger N, Mangen MJ.

Epidemiol Infect. 2015 Jul;143(9):1791-802. doi: 10.1017/S0950268814001940. Epub 2014 Dec 12. Review.

19.

Resource modelling: the missing piece of the HTA jigsaw?

Thokala P, Dixon S, Jahn B.

Pharmacoeconomics. 2015 Mar;33(3):193-203. doi: 10.1007/s40273-014-0228-9.

20.

Cost-effectiveness of the sequential application of tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia.

Rochau U, Sroczynski G, Wolf D, Schmidt S, Jahn B, Kluibenschaedl M, Conrads-Frank A, Stenehjem D, Brixner D, Radich J, Gastl G, Siebert U.

Leuk Lymphoma. 2015;56(8):2315-25. doi: 10.3109/10428194.2014.982635. Epub 2015 Jan 14.

PMID:
25393806
21.

Prioritization of Future Outcomes Research Studies in Chronic Myeloid Leukemia: Value of Information Analysis.

Rochau U, Kühne F, Jahn B, Kurzthaler C, Corro RI, Chhatwal J, Stollenwerk B, Goldhaber-Fiebert JD, Siebert U.

Value Health. 2014 Nov;17(7):A639. doi: 10.1016/j.jval.2014.08.2301. Epub 2014 Oct 26. No abstract available.

22.

Cost-Effectiveness Simulation of Colonography Versus Colonoscopy in Germany: Is Laxative-Free Colonography Cost-Effective?

Kriza C, Jahn B, Hassan C, Kolominsky-Rabas PL.

Value Health. 2014 Nov;17(7):A635. doi: 10.1016/j.jval.2014.08.2277. Epub 2014 Oct 26. No abstract available.

23.

Visualizing Methods For Discrete-Event-Simulations Using The Example Of A Breast Cancer Decision-Analytic Model.

Jahn B, Rochau U, Shterjovska J, Kurzthaler C, Kluibenschädl M, Urach C, Einzinger P, Piringer H, Popper N, Siebert U.

Value Health. 2014 Nov;17(7):A562. doi: 10.1016/j.jval.2014.08.1861. Epub 2014 Oct 26. No abstract available.

24.

Systematic Overview On Value-Of Information Analyses In Cancer Research.

Rochau U, Schnell-Inderst P, Burger EA, Baldauf M, Kühne F, Jahn B, Siebert U.

Value Health. 2014 Nov;17(7):A559. doi: 10.1016/j.jval.2014.08.1846. Epub 2014 Oct 26. No abstract available.

25.

A computational study of potential molecular switches that exploit Baird's rule on excited-state aromaticity and antiaromaticity.

Löfås H, Jahn BO, Wärnå J, Emanuelsson R, Ahuja R, Grigoriev A, Ottosson H.

Faraday Discuss. 2014;174:105-24. doi: 10.1039/c4fd00084f. Epub 2014 Oct 6.

PMID:
25284068
26.

Concepts of 'personalization' in personalized medicine: implications for economic evaluation.

Rogowski W, Payne K, Schnell-Inderst P, Manca A, Rochau U, Jahn B, Alagoz O, Leidl R, Siebert U.

Pharmacoeconomics. 2015 Jan;33(1):49-59. doi: 10.1007/s40273-014-0211-5.

27.

[Descriptive summary of the classical swine fever control in wild boar in Germany since 2005].

Staubach C, Höreth-Böntgen D, Blome S, Fröhlich A, Blicke J, Jahn B, Teuffert J, Kramers M.

Berl Munch Tierarztl Wochenschr. 2013 Nov-Dec;126(11-12):491-9. German.

PMID:
24511824
28.

Systematic assessment of decision-analytic models for chronic myeloid leukemia.

Rochau U, Schwarzer R, Jahn B, Sroczynski G, Kluibenschaedl M, Wolf D, Radich J, Brixner D, Gastl G, Siebert U.

Appl Health Econ Health Policy. 2014 Apr;12(2):103-15. doi: 10.1007/s40258-013-0071-8. Review.

PMID:
24385259
29.

Medical decision analysis for first-line therapy of chronic myeloid leukemia.

Rochau U, Sroczynski G, Wolf D, Schmidt S, Conrads-Frank A, Jahn B, Saverno K, Brixner D, Radich J, Gastl G, Siebert U.

Leuk Lymphoma. 2014 Aug;55(8):1758-67. doi: 10.3109/10428194.2013.858149. Epub 2014 Feb 6.

PMID:
24160847
30.

New Class of Molecular Conductance Switches Based on the [1,3]-Silyl Migration from Silanes to Silenes.

Löfås H, Orthaber A, Jahn BO, Rouf AM, Grigoriev A, Ott S, Ahuja R, Ottosson H.

J Phys Chem C Nanomater Interfaces. 2013 May 30;117(21):10909-10918. Epub 2013 Apr 5.

31.

Organic single molecular structures for light induced spin-pump devices.

Jahn BO, Ottosson H, Galperin M, Fransson J.

ACS Nano. 2013 Feb 26;7(2):1064-71. doi: 10.1021/nn3038622. Epub 2013 Jan 25.

PMID:
23350843
32.

State-transition modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--3.

Siebert U, Alagoz O, Bayoumi AM, Jahn B, Owens DK, Cohen DJ, Kuntz KM; ISPOR-SMDM Modeling Good Research Practices Task Force.

Value Health. 2012 Sep-Oct;15(6):812-20. doi: 10.1016/j.jval.2012.06.014.

33.

State-transition modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-3.

Siebert U, Alagoz O, Bayoumi AM, Jahn B, Owens DK, Cohen DJ, Kuntz KM.

Med Decis Making. 2012 Sep-Oct;32(5):690-700.

PMID:
22990084
34.

New methodology for estimating the burden of infectious diseases in Europe.

Kretzschmar M, Mangen MJ, Pinheiro P, Jahn B, Fèvre EM, Longhi S, Lai T, Havelaar AH, Stein C, Cassini A, Kramarz P; BCoDE consortium.

PLoS Med. 2012;9(4):e1001205. doi: 10.1371/journal.pmed.1001205. Epub 2012 Apr 17.

35.

Metal-free 1,5-regioselective azide-alkyne [3+2]-cycloaddition.

Kloss F, Köhn U, Jahn BO, Hager MD, Görls H, Schubert US.

Chem Asian J. 2011 Oct 4;6(10):2816-24. doi: 10.1002/asia.201100404. Epub 2011 Aug 31.

PMID:
21882350
36.

Decision-analytic models to simulate health outcomes and costs in heart failure: a systematic review.

Goehler A, Geisler BP, Manne JM, Jahn B, Conrads-Frank A, Schnell-Inderst P, Gazelle GS, Siebert U.

Pharmacoeconomics. 2011 Sep;29(9):753-69. doi: 10.2165/11585990-000000000-00000. Review.

PMID:
21557632
37.

Metal-mediated reaction modeled on nature: the activation of isothiocyanates initiated by zinc thiolate complexes.

Eger WA, Presselt M, Jahn BO, Schmitt M, Popp J, Anders E.

Inorg Chem. 2011 Apr 18;50(8):3223-33. doi: 10.1021/ic101464j. Epub 2011 Mar 15.

PMID:
21405064
38.

Anion complexation by triazolium "ligands": mono- and bis-tridentate complexes of sulfate.

Schulze B, Friebe C, Hager MD, Günther W, Köhn U, Jahn BO, Görls H, Schubert US.

Org Lett. 2010 Jun 18;12(12):2710-3. doi: 10.1021/ol100776x.

PMID:
20481556
39.

Tutorial in medical decision modeling incorporating waiting lines and queues using discrete event simulation.

Jahn B, Theurl E, Siebert U, Pfeiffer KP.

Value Health. 2010 Jun-Jul;13(4):501-6. doi: 10.1111/j.1524-4733.2010.00707.x. Epub 2010 Mar 22.

40.

[Establishing an advance directive--summary of practical experience].

Jahn B.

Wien Med Wochenschr. 2009;159(17-18):419-30. doi: 10.1007/s10354-009-0658-8. German.

PMID:
19823788
41.

Capacity constraints and cost-effectiveness: a discrete event simulation for drug-eluting stents.

Jahn B, Pfeiffer KP, Theurl E, Tarride JE, Goeree R.

Med Decis Making. 2010 Jan-Feb;30(1):16-28. doi: 10.1177/0272989X09336075. Epub 2009 Sep 29.

PMID:
19789389
42.

A prediction model for out-of-hospital cardiopulmonary resuscitation.

Pircher IR, Stadlbauer KH, Severing AC, Mayr VD, Lienhart HG, Jahn B, Lindner KH, Wenzel V.

Anesth Analg. 2009 Oct;109(4):1196-201. doi: 10.1213/ane.0b013e3181b15a70.

PMID:
19762749
43.

Peritumoral administration of GPI-anchored TIMP-1 inhibits colon carcinoma growth in Rag-2 gamma chain-deficient mice.

Raggi MC, Djafarzadeh R, Muenchmeier N, Hofstetter M, Jahn B, Rieth N, Nelson PJ.

Biol Chem. 2009 Sep;390(9):893-7. doi: 10.1515/BC.2009.098.

PMID:
19558322
44.

The zinc complex catalyzed hydration of alkyl isothiocyanates.

Eger WA, Jahn BO, Anders E.

J Mol Model. 2009 Apr;15(4):433-46. doi: 10.1007/s00894-008-0385-x. Epub 2008 Dec 16.

PMID:
19085026
45.

Improving countershock success prediction during cardiopulmonary resuscitation using ventricular fibrillation features from higher ECG frequency bands.

Neurauter A, Eftestøl T, Kramer-Johansen J, Abella BS, Wenzel V, Lindner KH, Eilevstjønn J, Myklebust H, Steen PA, Sterz F, Jahn B, Strohmenger HU.

Resuscitation. 2008 Dec;79(3):453-9. doi: 10.1016/j.resuscitation.2008.07.024. Epub 2008 Oct 26.

PMID:
18954929
46.

Allene as the parent substrate in zinc-mediated biomimetic hydration reactions of cumulenes.

Jahn BO, Eger WA, Anders E.

J Org Chem. 2008 Nov 7;73(21):8265-78. doi: 10.1021/jo801358m. Epub 2008 Oct 11.

PMID:
18847243
47.

Spontaneous abortion and the prophylactic effect of folic acid supplementation in epileptic women undergoing antiepileptic therapy.

Pittschieler S, Brezinka C, Jahn B, Trinka E, Unterberger I, Dobesberger J, Walser G, Auckenthaler A, Embacher N, Bauer G, Luef G.

J Neurol. 2008 Dec;255(12):1926-31. doi: 10.1007/s00415-008-0029-1. Epub 2008 Jul 25.

PMID:
18677647
48.

First occurrence of Culicoides obsoletus-transmitted Bluetongue virus epidemic in Central Europe.

Mehlhorn H, Walldorf V, Klimpel S, Jahn B, Jaeger F, Eschweiler J, Hoffmann B, Beer M.

Parasitol Res. 2007 Jun;101(1):219-28. Epub 2007 Mar 26. Erratum in: Parasitol Res. 2007 Aug;101(3):833-4.

PMID:
17385085
49.

C-reactive protein and leukocytes do not reliably indicate severity of influenza a infection in childhood.

Edelbauer M, Würzner R, Jahn B, Zimmerhackl LB.

Clin Pediatr (Phila). 2006 Jul;45(6):531-6.

PMID:
16893858
50.

Influence of negative expiratory pressure ventilation on hemodynamic variables during severe hemorrhagic shock.

Krismer AC, Wenzel V, Lindner KH, von Goedecke A, Junger M, Stadlbauer KH, Königsrainer A, Strohmenger HU, Sawires M, Jahn B, Hörmann C.

Crit Care Med. 2006 Aug;34(8):2175-81.

PMID:
16791108

Supplemental Content

Support Center